These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 25890455)

  • 1. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors.
    Two AM; Wu W; Gallo RL; Hata TR
    J Am Acad Dermatol; 2015 May; 72(5):749-58; quiz 759-60. PubMed ID: 25890455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosacea Pathogenesis.
    Ahn CS; Huang WW
    Dermatol Clin; 2018 Apr; 36(2):81-86. PubMed ID: 29499802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facial Erythema of Rosacea - Aetiology, Different Pathophysiologies and Treatment Options.
    Steinhoff M; Schmelz M; Schauber J
    Acta Derm Venereol; 2016 Jun; 96(5):579-86. PubMed ID: 26714888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosacea: clinical presentation and pathophysiology.
    Diamantis S; Waldorf HA
    J Drugs Dermatol; 2006 Jan; 5(1):8-12. PubMed ID: 16468286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The enigma of rosacea.
    Marks R
    J Dermatolog Treat; 2007; 18(6):326-8. PubMed ID: 18058493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into rosacea pathophysiology: a review of recent findings.
    Steinhoff M; Schauber J; Leyden JJ
    J Am Acad Dermatol; 2013 Dec; 69(6 Suppl 1):S15-26. PubMed ID: 24229632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physiopathology of rosacea. Redness, telangiectasia, and rosacea].
    Cribier B
    Ann Dermatol Venereol; 2011 Sep; 138 Suppl 2():S129-37. PubMed ID: 21907872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of rosacea: redness, telangiectasia, and rosacea.
    Cribier B
    Ann Dermatol Venereol; 2011 Nov; 138 Suppl 3():S184-91. PubMed ID: 22183097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathophysiology of rosacea.
    Mc Aleer MA; Lacey N; Powell FC
    G Ital Dermatol Venereol; 2009 Dec; 144(6):663-71. PubMed ID: 19907405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosacea: I. Etiology, pathogenesis, and subtype classification.
    Crawford GH; Pelle MT; James WD
    J Am Acad Dermatol; 2004 Sep; 51(3):327-41; quiz 342-4. PubMed ID: 15337973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosacea: clinical features and treatment.
    Lavers I
    Nurs Stand; 2016 Mar; 30(31):52-9; quiz 60. PubMed ID: 27027198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of rosacea with doxycycline monohydrate.
    Bikowski JB
    Cutis; 2000 Aug; 66(2):149-52. PubMed ID: 10955198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition.
    Woo YR; Lim JH; Cho DH; Park HJ
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link.
    Forton FM
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):19-28. PubMed ID: 22017468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current drug therapies for rosacea: a chronic vascular and inflammatory skin disease.
    Feldman SR; Huang WW; Huynh TT
    J Manag Care Spec Pharm; 2014 Jun; 20(6):623-9. PubMed ID: 24856600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation in rosacea and acne: Implications for patient care.
    Fleischer AB
    J Drugs Dermatol; 2011 Jun; 10(6):614-20. PubMed ID: 21961194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatments for rosacea.
    Layton AM
    Clin Dermatol; 2017; 35(2):207-212. PubMed ID: 28274361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rosacea: pathogenesis, clinical forms and therapy].
    Preisz K; Kárpáti S
    Orv Hetil; 2010 Jul; 151(30):1209-14. PubMed ID: 20650811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in understanding and managing rosacea.
    Buddenkotte J; Steinhoff M
    F1000Res; 2018; 7():. PubMed ID: 30631431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous and ocular rosacea: Common and specific physiopathogenic mechanisms and study models.
    Rodrigues-Braz D; Zhao M; Yesilirmak N; Aractingi S; Behar-Cohen F; Bourges JL
    Mol Vis; 2021; 27():323-353. PubMed ID: 34035646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.